Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995

Keyphrases

• Growth Inhibition 100%
• Tumor 100%
• Somatostatin Analogs 100%
• Human Pancreatic Adenocarcinoma 100%
• Treatment Group 60%
• Transplantation 60%
• DNA Content 60%
• RNA Content 40%
• Tumor Area 40%
• Tumor Weight 40%
• Pancreas 20%
• Inhibitory Effect 20%
• Pancreatic Cancer 20%
• Tumor Growth 20%
• Gastrointestinal 20%
• Somatostatin 20%
• Pancreatic Adenocarcinoma 20%
• Cholecystokinin 20%
• Nude Mice 20%
• Saline Solution 20%
• Hormonal Therapy 20%
• Between-group 20%
• Endocrine Tumors 20%
• Hormone Secretion 20%
• Intraperitoneal Injection 20%
• Twice Daily 20%
• Cholecystokinin Receptor 20%
• Human Pancreatic Cancer 20%
• Long-acting Analog 20%
• Tumor Doubling Time 20%

Medicine and Dentistry

• Neoplasm 100%
• Pancreas Adenocarcinoma 100%
• Somatostatin Derivative 100%
• Group Therapy 30%
• Malignant Neoplasm 20%
• Pancreas Cancer 20%
• Tumor Progression 10%
• Hormone Release 10%
• Cholecystokinin 10%
• Hormone Therapy 10%
• Body Weight 10%
• Somatostatin 10%
• Endocrine Tumor 10%
• RNA Analysis 10%
• Intraperitoneal Drug Administration 10%
• Cholecystokinin Receptor 10%

Veterinary Science and Veterinary Medicine

• Mouse 100%
• Somatostatin 100%
• Pancreatic Cancer 66%
• Cholecystokinin 66%